Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| platelet | 9 studies | 66% ± 15% | |
| megakaryocyte | 6 studies | 54% ± 28% |
Insufficient scRNA-seq data for expression of TREML1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 73% | 41.13 | 1929 / 2642 | 89% | 4.48 | 626 / 705 |
| lung | 98% | 113.17 | 569 / 578 | 42% | 0.89 | 482 / 1155 |
| breast | 64% | 27.25 | 296 / 459 | 45% | 0.90 | 505 / 1118 |
| adrenal gland | 94% | 51.85 | 242 / 258 | 12% | 0.18 | 28 / 230 |
| spleen | 100% | 348.75 | 240 / 241 | 0% | 0 | 0 / 0 |
| thymus | 62% | 16.97 | 406 / 653 | 31% | 0.67 | 187 / 605 |
| kidney | 36% | 8.44 | 32 / 89 | 49% | 1.10 | 442 / 901 |
| pancreas | 37% | 11.52 | 120 / 328 | 46% | 1.09 | 81 / 178 |
| peripheral blood | 81% | 1644.26 | 756 / 929 | 0% | 0 | 0 / 0 |
| prostate | 60% | 15.44 | 147 / 245 | 8% | 0.12 | 39 / 502 |
| adipose | 65% | 38.05 | 787 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 29% | 5.57 | 52 / 180 | 27% | 0.52 | 118 / 430 |
| blood vessel | 46% | 17.44 | 616 / 1335 | 0% | 0 | 0 / 0 |
| bladder | 24% | 4.24 | 5 / 21 | 18% | 0.35 | 90 / 504 |
| tonsil | 0% | 0 | 0 / 0 | 40% | 0.98 | 18 / 45 |
| intestine | 28% | 8.04 | 270 / 966 | 11% | 0.21 | 58 / 527 |
| uterus | 15% | 4.13 | 25 / 170 | 22% | 0.58 | 103 / 459 |
| liver | 30% | 6.85 | 67 / 226 | 7% | 0.18 | 27 / 406 |
| stomach | 16% | 3.09 | 57 / 359 | 20% | 0.31 | 57 / 286 |
| lymph node | 0% | 0 | 0 / 0 | 34% | 1.04 | 10 / 29 |
| skin | 10% | 1.94 | 182 / 1809 | 24% | 0.59 | 113 / 472 |
| esophagus | 12% | 2.45 | 179 / 1445 | 19% | 0.41 | 35 / 183 |
| heart | 29% | 7.55 | 247 / 861 | 0% | 0 | 0 / 0 |
| muscle | 4% | 0.76 | 36 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.04 | 2 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045087 | Biological process | innate immune response |
| GO_0030168 | Biological process | platelet activation |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0009986 | Cellular component | cell surface |
| GO_0031091 | Cellular component | platelet alpha granule |
| GO_0005829 | Cellular component | cytosol |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0016020 | Cellular component | membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004888 | Molecular function | transmembrane signaling receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TREML1 |
| Protein name | Trem-like transcript 1 protein (TLT-1) (Triggering receptor expressed on myeloid cells-like protein 1) |
| Synonyms | UNQ1825/PRO3438 TLT1 |
| Description | FUNCTION: Cell surface receptor that may play a role in the innate and adaptive immune response. . |
| Accessions | ENST00000437044.2 [Q86YW5-3] ENST00000373127.8 [Q86YW5-2] ENST00000426005.7 [Q86YW5-1] Q86YW5 |